BLC Stock Overview
Bangkok Lab And Cosmetic Public Company Limited manufacturing and distributing of pharmaceuticals and medicinal chemical products for humans and animals in Thailand, Laos, Cambodia, Hongkong, Vietnam, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
Bangkok Lab And Cosmetic Public Company Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ฿5.35 |
| 52 Week High | ฿6.30 |
| 52 Week Low | ฿4.00 |
| Beta | 0 |
| 11 Month Change | 3.88% |
| 3 Month Change | 4.90% |
| 1 Year Change | 31.77% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -25.69% |
Recent News & Updates
Recent updates
Shareholder Returns
| BLC | TH Pharmaceuticals | TH Market | |
|---|---|---|---|
| 7D | -0.9% | -4.8% | 0.8% |
| 1Y | 31.8% | 8.0% | 3.1% |
Return vs Industry: BLC exceeded the TH Pharmaceuticals industry which returned 8% over the past year.
Return vs Market: BLC exceeded the TH Market which returned 3.1% over the past year.
Price Volatility
| BLC volatility | |
|---|---|
| BLC Average Weekly Movement | 4.3% |
| Pharmaceuticals Industry Average Movement | 6.2% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in TH Market | 10.3% |
| 10% least volatile stocks in TH Market | 2.4% |
Stable Share Price: BLC has not had significant price volatility in the past 3 months compared to the TH market.
Volatility Over Time: BLC's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2022 | n/a | Suvit Ngampoopun | bangkoklab.co.th |
Bangkok Lab And Cosmetic Public Company Limited manufacturing and distributing of pharmaceuticals and medicinal chemical products for humans and animals in Thailand, Laos, Cambodia, Hongkong, Vietnam, and internationally. The company distributes food supplements, cosmeceuticals, and pharmaceutical drugs; medicine, medical supplies, tonics, and supplements for animals; and supplementary food and herbs. It also engages in provision of management consulting and logistic services; and export of cosmeceuticals, pharmaceutical drugs, medicines, herbs, and cosmetics.
Bangkok Lab And Cosmetic Public Company Limited Fundamentals Summary
| BLC fundamental statistics | |
|---|---|
| Market cap | ฿3.21b |
| Earnings (TTM) | ฿166.85m |
| Revenue (TTM) | ฿1.55b |
19.2x
P/E Ratio2.1x
P/S RatioIs BLC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BLC income statement (TTM) | |
|---|---|
| Revenue | ฿1.55b |
| Cost of Revenue | ฿674.56m |
| Gross Profit | ฿876.45m |
| Other Expenses | ฿709.59m |
| Earnings | ฿166.85m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.28 |
| Gross Margin | 56.51% |
| Net Profit Margin | 10.76% |
| Debt/Equity Ratio | 9.6% |
How did BLC perform over the long term?
See historical performance and comparison